Filing Flows

Filing Flows › Xwell (XWEL) › Q3 2025

Xwell (XWEL) Q3 2025 earnings results (third quarter 2025)

10-Q filed Nov 14, 2025

Xwell (XWEL) reported revenue of $7.3M for the third quarter 2025 (Q3 2025), -13% from a year earlier and -4% from the quarter before. Operating margin was -10.5%, net loss $211K (2.9% of revenue).

Revenue$7.3M
Year over year-13%
Quarter over quarter-4%
Operating margin-10.5%
Net earnings−$211K

Xwell, Q3 2025: revenue $7.3M (-13% year over year), operating margin -10.5%, net loss $211K, operating cash flow −$2.1M. The chart follows the revenue to costs, profit and cash.

Q3 2025AmountQ/QY/Y
Revenue$7.3M-4%-13%
Operating profit−$770K——
Net earnings−$211K——
Operating cash flow−$2.1M——

What changed

Revenue was $7.3M in Q3 2025, down 13% year over year and down 4% from the previous quarter. XpresSpa was the largest line at 66% of revenue. XpresTest lost $1.1M year over year (down 35%), 103% of the total change.

Gross margin was 20.3%, down 4.0 points from a year earlier. Operating costs exceeded revenue by $770K, an operating margin of -10.5%. Operating expenses fell 67% while revenue fell 13%. The fastest-growing cost line was Other operating costs (+75%). The quarter ended with a net loss of $211K, narrower than the previous quarter's $2.1M loss. Non-operating items added $561K, -268% of pre-tax earnings, so the bottom line overstates operating performance.

Operating cash flow was −$2.1M. Non-cash charges added back $221K of depreciation and amortization and $237K of share-based compensation. Working capital and other items used $2.4M. Capital expenditures of $945K exceeded it, leaving free cash flow of −$3.1M.

Questions

What was Xwell's revenue in the third quarter 2025?

Xwell (XWEL) reported revenue of $7.3M for the third quarter 2025 (Q3 2025), -13% from a year earlier and -4% from the quarter before.

Was Xwell profitable in the third quarter 2025?

Operating loss was $770K (-10.5% of revenue) and net loss $211K.

Open the interactive Sankey →

Source: Xwell 10-Q on SEC EDGAR.